?> Contact us Follow Us
Biosimilars Forum
  • About Us
    • Members
    • Executive Director
  • Why Biosimilars
    • The Issue
    • Our Solutions
  • Biosimilars 101
    • Foundations
    • Core Principles
    • FDA Regulatory Tenets
    • Biosimilars FAQs
    • Future Evolution of Biosimilar Development
    • Approved Biosimilars
  • Advocacy
    • Our Action
    • Tools
  • News
  • Resources
  • Get Involved
    • Partners

Katie Quinn

Get more out of your business.
Reach it with Microsoft Dynamics 365 Business Central.
News
September 3, 2015 Katie Quinn
Biosimilars Forum Statement on the Introduction of Biosimilars in the United States
News
August 27, 2015 Katie Quinn
Forum Statement on Proposed FDA Guidance on Naming of Biological Products
News
August 5, 2015 Katie Quinn
Biosimilars Forum Applauds Reps. Barton, Eshoo for Leadership on Proposed Medicare Rule on Biosimilar Coding
News
July 9, 2015 Katie Quinn
Biosimilars Forum Expresses Concern with CMS Proposed Rule on Biosimilar Payment and Coding
News
May 5, 2015 Katie Quinn
Biosimilars Forum Statement Regarding the Need for Appropriate Coding for Biosimilars
News
May 5, 2015 Katie Quinn
New Forum Launches to Expand Access to Biosimilar Medicines, Improve Health Care
  • Prev page
  • 06
  • 07
  • 08

  • Biosimilars 101
  • Biosimilars FAQs
  • Advocacy
  • Stay Connected
Biosimilars Forum
© 2025 Biosimilars Forum. All rights reserved.
  • Terms of Use
  • |
  • Privacy Policy
  • |
  • Contact Us